Future prospects of EGFR-TKIs and surgery for non-small-cell lung cancer

被引：0
|
作者：
Nagano, Tatsuya [1 ]
Tachihara, Motoko [1 ]
Tanaka, Yugo [2 ]
机构：
[1] Kobe Univ, Dept Internal Med, Div Resp Med, Grad Sch Med, Kobe, Hyogo, Japan
[2] Kobe Univ, Div Thorac Surg, Grad Sch Med, Kobe, Hyogo, Japan
来源：
JOURNAL OF THORACIC DISEASE | 2022年 / 14卷 / 04期
关键词：
OSIMERTINIB;
D O I：
10.21037/jtd-22-57
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：809 / 811
页数：3
相关论文
共 50 条
  • [31] Clinical efficacy of first-generation EGFR-TKIs in patients with advanced non-small-cell lung cancer harboring EGFR exon 20 mutations
    Chen, Dan
    Song, Zhengbo
    Cheng, Guoping
    ONCOTARGETS AND THERAPY, 2016, 9 : 4181 - 4186
  • [32] Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study
    Wenxian Wang
    Lan Shao
    Yibing Xu
    Zhengbo Song
    Guangyuan Lou
    Yiping Zhang
    Ming Chen
    BMC Pulmonary Medicine, 22
  • [33] Efficacy of EGFR-TKIs with or without angiogenesis inhibitors in advanced non-small-cell lung cancer: A systematic review and meta-analysis
    Chen, Zhaoxin
    Wei, Jia
    Ma, Xiaoting
    Yu, Jing
    JOURNAL OF CANCER, 2020, 11 (03): : 686 - 695
  • [34] Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study
    Wang, Wenxian
    Shao, Lan
    Xu, Yibing
    Song, Zhengbo
    Lou, Guangyuan
    Zhang, Yiping
    Chen, Ming
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [35] Impact of Sex and Smoking on the Efficacy of EGFR-TKIs in Terms of Overall Survival in Non-small-Cell Lung Cancer: A Meta-Analysis
    Xiao, Jian
    Zhou, Liang
    He, Bixiu
    Chen, Qiong
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [36] Therapeutic efficacy comparison of six major EGFR-TKIs in non-small-cell lung cancer patients with an activating EGFR mutation: A network meta-analysis.
    Wu, Fang
    He, Jingyi
    Wu, Sixuan
    Huang, Yan
    Li, Yizheng
    Zhao, Lishu
    Hu, Chunhong
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] Impact of minocycline on outcomes of EGFR-mutant non-small cell lung cancer patients treated with EGFR-TKIs
    Mari Tone
    Kota Iwahori
    Takayuki Shiroyama
    Shinji Futami
    Yujiro Naito
    Kiyoharu Fukushima
    Kotaro Miyake
    Shohei Koyama
    Haruhiko Hirata
    Izumi Nagatomo
    Hisashi Wada
    Yoshito Takeda
    Atsushi Kumanogoh
    Scientific Reports, 13
  • [38] EGFR-TKIs combined with chemotherapy versus EGFR-TKIs single agent as first-line treatment for molecularly selected patients with non-small cell lung cancer
    Sheng, Zhixin
    Zhang, Yanxia
    MEDICAL ONCOLOGY, 2015, 32 (01) : 1 - 7
  • [39] Relative efficacies of EGFR-TKIs and immune checkpoint inhibitors for treatment of recurrent non-small cell lung cancer after surgery
    Motono, Nozomu
    Mizoguchi, Takaki
    Ishikawa, Masahito
    Iwai, Shun
    Iijima, Yoshihito
    Uramoto, Hidetaka
    ONCOLOGY, 2024, 102 (06) : 476 - 483
  • [40] A meta-analysis of adjuvant EGFR-TKIs for patients with EGFR mutation of resected non-small cell lung cancer
    Cui, Ran
    Wei, Chun
    Li, Xianyi
    Jiang, Ou
    MEDICINE, 2022, 101 (47) : E31894
12345